Peptonic Medical

"We are delighted to enhance our collaboration with GMS Healthcare Group. Our acquisition of Israeli CommonSense highlighted the innovation potential of the amniocentesis leakage test that could pave the way for additional products to be added when we sign partner agreements.  This important extended agreement is an excellent illustration," said Erik Sundquist, CEO of Peptonic.

During the third quarter of 2022, Peptonic signed an exclusive distribution agreement with GMS Healthcare Group regarding Peptonic patented amniocentesis leak test in the UAE.

After a successful launch of the test in the UAE in the first quarter of 2023, GMS Healthcare Group now expand its collaboration with Peptonic Medical. An exclusive supplementary agreement has been signed for the following products:

• VagiVital VS Pro, a professional version of Peptonics’s patented test for vaginal infections.
• VagiVital AktivGel, a treatment for vaginal atrophy
• VagiVital Moisturizing V Cleanser, a moisturizing intimate cleanser

"GMS Healthcare has an extensive network in UAE, and we value their approach towards education and service," says Erik Sundquist

"We started our partnership with Peptonic around the company's patented amniocentesis leak test. We are very pleased to now expand the collaboration with more products from Peptonic's innovative women's health portfolio", says Bishnu Bahadur Adhikari, CEO of GMS Healthcare Group.